A NOVEL HIGHLY SELECTIVE 5-HYDROXYTRYPTAMINE 2B (5-HT2B) RECEPTOR ANTAGONIST AMELIORATING FIBROSIS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS

被引：3
|
作者：
Wenglen, C. [1 ]
Pettersson, L. [1 ]
Arozenius, H. [1 ]
Ekstrom, G. [1 ]
机构：
[1] ANAMAR, Lund, Sweden
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.3750
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0314
引用
收藏
页码：891 / 891
页数：1
相关论文
共 50 条
  • [1] A Novel Highly Selective 5-Hydroxytryptamine 2B (5-HT2B) Receptor Antagonist Ameliorating Fibrosis in Preclinical Models of Systemic Sclerosis
    Wenglen, Christina
    Pettersson, Lars
    Arozenius, Helena
    Ekstrom, Gunilla
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [2] AN ORALLY AVAILABLE HIGHLY SELECTIVE 5-HYDROXYTRYPTAMINE 2B (5-HT2B) RECEPTOR ANTAGONIST AMELIORATING PULMONARY AND DERMAL FIBROSIS IN PRECLINICAL MODELS OF SYSTEMIC SCLEROSIS
    Wenglen, Christina
    Arozenius, Helena
    Pettersson, Lars
    Ekstrom, Gunilla
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 457 - 458
  • [3] An orally available, highly selective 5-hydroxytryptamine 2B (5-HT2B) receptor antagonist ameliorating pulmonary and dermal fibrosis
    Wenglen, Christina
    Arozenius, Helena
    Pettersson, Lars
    Ekstrom, Gunilla
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [4] An Orally Available Highly Selective 5-Hydroxytryptamine 2B Receptor Antagonist Ameliorating Pulmonary and Dermal Fibrosis in Preclinical Models of Systemic Sclerosis
    Wenglen, Christina
    Arozenius, Helena
    Pettersson, Lars
    Ekstrom, Gunilla
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] A New Highly Selective 5-Hydroxytryptamine 2b (5-Ht2b) Receptor Antagonist With Anti-Fibrotic Effects In Models Of Lung Fibrosis
    Wenglen, C.
    Pettersson, L.
    Arozenius, H.
    Ekstrom, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] Predictive In Silico Studies of Human 5-hydroxytryptamine Receptor Subtype 2B (5-HT2B) and Valvular Heart Disease
    Reid, Terry-Elinor
    Kumar, Krishna
    Wang, Xiang Simon
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (11) : 1353 - 1362
  • [7] [3H]Rauwolscine: An antagonist radioligand for the cloned human 5-hydroxytryptamine(2B) (5-HT(2B)) receptor
    Wainscott D.B.
    Sasso D.A.
    Kursar J.D.
    Baez M.
    Lucaites V.L.
    Nelson D.L.
    Naunyn-Schmiedeberg's Archives of Pharmacology, 1997, 357 (1) : 17 - 24
  • [8] THE PHARMACOLOGY AND DISTRIBUTION OF HUMAN 5-HYDROXYTRYPTAMINE(2B) (5-HT2B) RECEPTOR GENE-PRODUCTS - COMPARISON WITH 5-HT2A AND 5-HT2C RECEPTORS
    BONHAUS, DW
    BACH, C
    DESOUZA, A
    SALAZAR, FHR
    MATSUOKA, BD
    ZUPPAN, P
    CHAN, HW
    EGLEN, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (04) : 622 - 628
  • [9] Evaluation of a selective 5-hydroxytryptamine 2B receptor antagonist designed to alter the fibrotic process
    Wenglen, Christina
    Pettersson, Lars
    Arozenius, Helena
    Ekstrom, Gunilla
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [10] New selective 5-HT2B receptor antagonists for the treatment of fibrosis
    Pettersson, Lars
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
12345